PA

Prajwal Arora

Active Director Director DIN 08424500
DIN 08424500 First appointment Apr 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Apr 2019
Shareholding value •••• Premium profile

About Prajwal Arora

Data last updated:

Prajwal Arora is a Director at Famberz Biotech Private Limited (since 2022), Director at Bhagwan Dass Pharmaceutical Limited (since 2020) and Director at Petula Pharmaceuticals Private Limited (since 2022), and holds 1 more current directorship. The companies operate in Healthcare, Pharma and Food And Beverages. The 3 current companies with reported revenue have a combined latest revenue of ₹4.6 Lakh; the largest is Famberz Biotech Private Limited at ₹3.5 Lakh (FY 2025). Earlier, Prajwal Arora was a Director at Jiwanda Pharma Private Limited (2019–2024) and Additional Director at All India Film Distributors Private Limited (from 2020).

DIN 08424500
Primary Designation Director
Industry Healthcare
First Appointment 18 Apr 2019
Oldest Company Age 71 yrs
Largest company Famberz Biotech Private Limited · ₹3.5 Lakh (FY 2025)
Combined revenue ₹4.6 Lakh across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Famberz Biotech Private Limited U24100DL2015PTC287182
Director27 Dec 20222015₹3.5 Lakh (FY 2025)Active
Bhagwan Dass Pharmaceutical Limited U24304DL2020PLC360532
Director21 Jan 20202020₹74,630 (FY 2025)Active
Director27 Dec 20222007₹30,500 (FY 2024)Active
Director18 Apr 20192017Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jiwanda Pharma Private Limited U74899DL1993PTC052743
Director18 Apr 20191993Active
Additional Director13 Jan 20201955₹13,000 (FY 2018)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Prajwal Arora

Directorship timeline

Open interactive timeline →
Famberz Biotech Private Limited
Petula Pharmaceuticals Private Limited
Shri Jiwanda Ram Biotech Private Limited
Bhagwan Dass Pharmaceutical Limited
Premium access

Shareholding and investment profile for Prajwal Arora

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prajwal Arora

Prajwal Arora currently holds 4 directorships: Famberz Biotech Private Limited (Director, since 27 Dec 2022, revenue ₹3.5 Lakh (FY 2025)); Bhagwan Dass Pharmaceutical Limited (Director, since 21 Jan 2020, revenue ₹74,630 (FY 2025)); Petula Pharmaceuticals Private Limited (Director, since 27 Dec 2022, revenue ₹30,500 (FY 2024)); Shri Jiwanda Ram Biotech Private Limited (Director, since 18 Apr 2019).

Prajwal Arora was first appointed on 18 Apr 2019 as Director at Shri Jiwanda Ram Biotech Private Limited. The most recent appointment on record is 27 Dec 2022 at Petula Pharmaceuticals Private Limited.

The 3 current companies of Prajwal Arora that report revenue have a combined latest revenue of ₹4.6 Lakh: Famberz Biotech Private Limited ₹3.5 Lakh (FY 2025); Bhagwan Dass Pharmaceutical Limited ₹74,630 (FY 2025); Petula Pharmaceuticals Private Limited ₹30,500 (FY 2024).

Prajwal Arora held 2 earlier board appointments: Jiwanda Pharma Private Limited (Director, 18 Apr 2019 to 22 Aug 2024); All India Film Distributors Private Limited (Additional Director, from 13 Jan 2020).

The current boards of Prajwal Arora's companies include Namrata Arora (Famberz Biotech Private Limited), Rekha Sareen (Bhagwan Dass Pharmaceutical Limited), Praveen Kumar (Shri Jiwanda Ram Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available